A Phase II trial of docetaxel and carboplatin administered every two weeks as preoperative therapy for stage II or III breast cancer: NCCTG Study N0338

OBJECTIVE: We conducted a multicenter phase II trial to assess the efficacy and toxicity of docetaxel (D) and carboplatin (C) combination as neoadjuvant therapy for stage II or III breast cancer (BC). METHODS: Patients received D 75 mg/m(2) and C AUC 6 on day 1 followed by pegfilgrastim on day 2, ev...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Roy, Vivek, Pockaj, Barbara A., Allred, Jacob B., Apsey, Heidi, Northfelt, Donald W., Nikcevich, Daniel, Mattar, Bassam, Perez, Edith A.
Format: Artigo
Langue:Inglês
Publié: 2013
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3493827/
https://ncbi.nlm.nih.gov/pubmed/22868240
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/COC.0b013e318256f619
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires